250 Patient-reported outcomes among patients (pts) with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor (IVA) compared with those homozygous for the F508del-CFTR mutation

Mainz, J.G.; Narayanan, S.; Suthoff, Ellison; Vallier, C.; Bell, S.C.; MacGregor, Gordon; Herzig, M.; Hautamaki, E.; Kinnman, Nils

doi:10.1016/s1569-1993(16)30489-1

Journal of Cystic Fibrosis

2016

DOI: 10.1016/s1569-1993(16)30489-1

|View full text |Cite

250 Patient-reported outcomes among patients (pts) with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor (IVA) compared with those homozygous for the F508del-CFTR mutation

J.G. Mainz¹,

S. Narayanan²,

Ellison Suthoff³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Adherence to therapies in cystic fibrosis: a targeted literature review

Narayanan¹,

Mainz

Gala³

et al. 2017

Expert Review of Respiratory Medicine

View full text Add to dashboard Cite

Cystic fibrosis (CF) is a life-shortening condition with no cure. Available therapies relieving the symptoms of CF are complex and time-consuming. A comprehensive review assessing adherence to different CF therapies, association of adherence with outcomes, and factors influencing adherence could inform optimal patient management strategies. Areas covered: A targeted literature review of studies published from 2010-2016 assessed adherence to CF therapies. Nineteen studies qualified for inclusion. Adherence to CF therapies was sub-optimal, and varied by treatment, mode of treatment administration, age, season, time and method of adherence measurement. Adherence to ivacaftor and inhaled antibiotics were reported higher than dornase alfa or hypertonic saline, oral pancreatic enzyme and vitamin supplements, and airway clearance therapy. Several patient, healthcare provider and treatment related factors influenced adherence. Sub-optimal adherence was shown to impact clinical and economic burden of the disease. Expert commentary: Higher adherence to CF therapies can lower disease burden, and improve patient outcomes. Healthcare providers and policy makers should devise patient-centered and caregiver-enabled interventions to improve adherence. Research on long-term adherence and outcomes associated with promising oral treatments such as CFTR modulators is needed. Identifying ways to overcome key barriers to adherence can positively affect outcomes associated with CF.

show abstract

Adherence to therapies in cystic fibrosis: a targeted literature review

Narayanan¹,

Mainz

Gala³

et al. 2017

Expert Review of Respiratory Medicine

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

250 Patient-reported outcomes among patients (pts) with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor (IVA) compared with those homozygous for the F508del-CFTR mutation

Cited by 1 publication

References 0 publications

Adherence to therapies in cystic fibrosis: a targeted literature review

Adherence to therapies in cystic fibrosis: a targeted literature review

Contact Info

Product

Resources

About